Tadalafil Manufacturers in India: Company and Brand Map

Indian Tadalafil Companies and Their Documented Products

The master table distinguishes direct manufacturing evidence from marketer or product-catalog relationships. That distinction is important because a brand owner, marketer and physical manufacturer can be the same company, related companies or entirely separate entities.

Strengths are included only to identify the documented product portfolio. They are not dosing recommendations, and a listed Indian or export-market strength does not establish approval or therapeutic equivalence in another jurisdiction.

Manufacturer, Marketer and Brand Owner Are Not Always the Same

Pharmaceutical product records use several company roles that should not be treated as synonyms. A manufacturer physically produces the drug product or performs a defined manufacturing operation, while a marketer places the product on the market under its commercial identity. A brand owner may control the trade name even when another facility performs manufacturing.

Some pharmacy databases combine these roles into a single field such as "manufacturer/marketer," which is useful for product identification but not sufficient to prove the exact manufacturing relationship. Stronger manufacturer attribution comes from a regulator, an official label or a company statement that explicitly identifies the company as manufacturer.

For this reason, the table above deliberately uses phrases such as "company catalog lists" or "marketer" where the evidence does not justify a stronger manufacturing claim.

Cipla and Tadacip

Cipla's current generic product catalog lists TADACIP 20 under its PDE inhibitor section, with tadalafil 20 mg and tablet dosage form. That is strong primary-source evidence that Tadacip is part of Cipla's documented product portfolio.

The catalog entry itself is sufficient to establish the Cipla-to-Tadacip product relationship, but it does not need to be stretched into a claim about which Cipla facility produced every pack. The wider company portfolio is covered on Cipla tadalafil, while finished-product identity belongs on the Tadacip page.

Sun Pharma Lists Both Forzest and Modula

Sun Pharmaceutical Industries' current India product catalog lists two distinct tadalafil brands in its sex-stimulant/rejuvenator category. FORZEST is listed as a tadalafil 20 mg tablet, while MODULA is listed as a tadalafil 5 mg tablet.

The presence of two brands under the same company illustrates why manufacturer and brand research need different page structures. The company-level portfolio is covered on Sun Pharma tadalafil, while individual product positioning belongs on Forzest and Modula.

Dr. Reddy's: Tazzle Brand Association and Tadalafil Manufacturing Evidence

Current Indian pharmacy records identify Dr. Reddy's Laboratories with the Tazzle tadalafil product family, including 5 mg, 10 mg and 20 mg presentations. Depending on the source, the company field may be described as marketer or as a combined manufacturer/marketer entry.

Separate Dr. Reddy's documentation provides stronger evidence that the company has manufactured tadalafil tablets in India for regulated export markets. For example, official product-compliance documentation for tadalafil 20 mg identifies Dr. Reddy's Laboratories Limited in India as the manufacturing location.

Those two facts should remain distinct: Dr. Reddy's has documented tadalafil manufacturing capability, while the precise role attached to a particular Tazzle listing should follow the source used for that product. The wider company context belongs on Dr. Reddy's tadalafil, while brand detail belongs on the Tazzle page.

Intas Pharmaceuticals and Filda

Intas Pharmaceuticals' current product catalog lists FILDA in its urology portfolio with tadalafil 20 mg. This is direct company-source evidence for the relationship between Intas, the Filda brand and the documented 20 mg tadalafil presentation.

The catalog proves product-portfolio association without requiring an unsupported statement about a particular manufacturing plant. Broader company-level tadalafil context is covered on Intas tadalafil, while the finished-product identity is covered on the Filda page.

Macleods Has Direct Manufacturer Evidence for Megalis

Macleods Pharmaceuticals has one of the clearer manufacturer relationships in this group because regulatory product records explicitly name Macleods Pharmaceuticals Ltd. as the manufacturer of Megalis tadalafil tablets. Active regulatory records document Megalis 10 mg and 20 mg with Macleods as the Indian manufacturer.

Current Indian pharmacy listings also associate Macleods with Megalis 5 mg, 10 mg and 20 mg presentations, although those retail databases may use marketer or combined manufacturer/marketer terminology. Together, the evidence supports both the company-brand relationship and direct manufacture of at least documented Megalis products.

The broader company portfolio belongs on Macleods tadalafil, while strength-level and finished-product details belong on the Megalis page.

Sunrise Remedies Explicitly Identifies Itself as Tadarise Manufacturer

Sunrise Remedies provides unusually direct manufacturer attribution on its own current Tadarise product page. The company identifies Sunrise Remedies Pvt. Ltd. as the manufacturer and states that Tadarise is manufactured by the company in India.

The same primary source lists tadalafil tablet strengths of 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg. Sunrise also publishes separate tadalafil-only specialty formulations and tadalafil-plus-dapoxetine combination products under related names.

The broad catalog makes Sunrise a useful example of why a manufacturer hub should map product families while leaving company-level depth to Sunrise Remedies tadalafil and individual formulation detail to the Tadarise page.

Centurion Laboratories and the Vidalista Product Family

Centurion Laboratories describes itself as a manufacturer of tadalafil tablets and lists multiple Vidalista products in its own catalog. Current examples include Vidalista 5 mg, Vidalista 10 mg, Vidalista 20 mg and Vidalista CT 20 mg chewable tablets, alongside additional tadalafil products.

The company page therefore provides direct manufacturer-level evidence rather than a retailer-only association. At the same time, not every product in Centurion's broader tadalafil catalog carries the Vidalista name, so company portfolio and brand portfolio should remain separate concepts.

There is no dedicated Centurion tadalafil company page in the current canonical sitemap, so product-specific information routes to the Vidalista page rather than inventing a new company URL.

Ajanta Pharma: Tadafil Marketer and Documented Tadalafil Manufacturer

Current Indian pharmacy records identify Ajanta Pharma Limited as the marketer of Tadafil 10 mg and 20 mg tadalafil tablets. Because those records specifically use marketer terminology, the Tadafil relationship should be described that way rather than automatically calling Ajanta the manufacturer of every Tadafil pack.

Ajanta is nevertheless a directly documented tadalafil manufacturer in other product contexts. Current U.S. DailyMed labeling identifies tadalafil tablets in 2.5 mg, 5 mg, 10 mg and 20 mg strengths as manufactured by Ajanta Pharma Limited in India, and Ajanta's U.S. product site also lists its approved tadalafil products.

That distinction makes Ajanta a useful example of why evidence should be product-specific: the company is demonstrably a tadalafil manufacturer, while current Indian Tadafil evidence separately establishes Ajanta as marketer. Broader company context belongs on Ajanta Pharma tadalafil, while Tadafil itself is covered on the Tadafil page.

Indian Companies Differ in Tadalafil Portfolio Breadth

Not every company approaches tadalafil with the same product architecture. Some company catalogs show a narrowly defined brand-strength pair, such as Tadacip 20 mg or Filda 20 mg, while others document multiple brands or broad strength ranges.

Sun Pharma, for example, currently lists both Forzest 20 mg and Modula 5 mg. Sunrise Remedies and Centurion Laboratories show wider tadalafil portfolios that extend beyond a single tablet strength or presentation.

Portfolio breadth is useful company-level information, but it should not be interpreted as a ranking of quality, effectiveness or suitability.

Company Research Is Different From Brand Research

A manufacturer-focused page answers which pharmaceutical companies are connected to tadalafil products and what role the evidence supports. A brand-focused page answers what a named product contains, which strengths and forms are documented and how it fits the broader tadalafil market.

Keeping those intents separate reduces duplication. Readers looking for a cross-brand product directory should use Indian tadalafil brands, while company-specific depth routes to the relevant manufacturer child pages rather than being repeated in this hub.

The distinction is especially useful when one company has multiple brands or when the same company manufactures generic tadalafil for one market but markets a named brand in another.

An Indian Company Relationship Does Not Define Every Market

An Indian pharmaceutical company may manufacture tadalafil for export, market an Indian branded product, supply a generic under a different label abroad or manufacture for another company's distribution chain. Those are separate regulatory and commercial relationships.

For example, Ajanta has documented U.S. tadalafil products manufactured in India while Tadafil appears under Ajanta marketer listings in India. Dr. Reddy's likewise has documented tadalafil manufacturing for export markets while Tazzle is a distinct Indian brand identity.

A company's Indian origin therefore should not be used as a shortcut for the approval status, brand name or therapeutic-equivalence status of every tadalafil product associated with that company.

Indian Manufacturing Does Not Automatically Mean Cialis Equivalence

Companies in India manufacture many high-quality regulated generic medicines, including tadalafil products for markets with formal approval systems. However, the manufacturing country or company name by itself is not enough to establish that a specific Indian-market brand is therapeutically equivalent to Cialis in the United States or another jurisdiction.

U.S. generic-equivalence status depends on the applicable FDA approval and reference-product framework. An FDA-approved tadalafil product manufactured by an Indian company can therefore have a different regulatory status from another brand sold by the same company in India.

The regulatory meaning of generic tadalafil is covered more fully on the generic tadalafil page.

What Counts as Strong Evidence for a Tadalafil Manufacturer Claim?

The strongest evidence for a manufacturing relationship is product-specific: an official label, government regulatory record or company statement that explicitly names the manufacturer. A company catalog is strong evidence that a product belongs to the company's portfolio, but it may not identify the plant or legal manufacturing entity.

Current pharmacy listings are valuable for market identity and marketer information, particularly when primary company documentation is unavailable. They should be quoted using the role they actually provide rather than silently converting marketer into manufacturer.

This evidence hierarchy is why some entries on this page use more cautious terminology than others.

Common Misunderstandings About Indian Tadalafil Manufacturers

One common mistake is to call every company attached to an Indian tadalafil brand its manufacturer. That can be correct in some cases, but the evidence may only establish a marketer or portfolio relationship in others.

A second mistake is to assume that all products from one company have the same regulatory status. Large companies can manufacture FDA-approved generic tadalafil for one market while also marketing different branded products under Indian regulatory and commercial frameworks.

Finally, the number of tadalafil brands or strengths in a company's portfolio is not evidence that the company is clinically superior to another manufacturer. This page maps entities and products rather than ranking companies.

Key Takeaways: Tadalafil Manufacturers in India

Several Indian pharmaceutical companies have well-documented relationships with tadalafil products, but the evidence supports different roles. Cipla, Sun Pharma and Intas directly list tadalafil brands in their company catalogs; Sunrise Remedies and Centurion Laboratories explicitly present themselves as manufacturers of their tadalafil product families; and Macleods is named as Megalis manufacturer in regulatory product records.

Dr. Reddy's and Ajanta Pharma illustrate why roles should be separated by product. Both have documented tadalafil manufacturing activity in India, while current Indian brand records also identify Dr. Reddy's with Tazzle and Ajanta as marketer of Tadafil.

The safest way to build a company-to-brand map is therefore to preserve the terminology used by the strongest available source. Manufacturer, marketer, brand owner and product-catalog association are related concepts, but they are not interchangeable.